Finance

Lists
SRTA:NASDAQ
Strata Critical Medical Inc
4,53 $
+1,34%
(+0,060) 1D
4,53 $
0,00% (0,00)
After hours
Closed: 9 հոկ, 16:00:00 GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for SRTA...
Open
4,47 $
High
4,58 $
Low
4,40 $
Mkt. cap
400,75 մլն
Avg. vol.
838,26 հզր
Volume
623,11 հզր
P/E ratio
9,17
52-wk high
6,50 $
52-wk low
3,95 $
EPS
0,49 $
Beta
2,43
Shares outstanding
88,47 մլն
No. of employees
327
Open
4,47 $
High
4,58 $
Low
4,40 $
Mkt. cap
400,75 մլն
Avg. vol.
838,26 հզր
Volume
623,11 հզր
P/E ratio
9,17
52-wk high
6,50 $
52-wk low
3,95 $
EPS
0,49 $
Beta
2,43
Shares outstanding
88,47 մլն
No. of employees
327
News stories
From web sources and news partners
About Strata Critical Medical Inc
CEO-
Employees327
Founded2014
Headquarters-
SectorHealth care provider
Analyst ratings
Based on 1 analyst giving stock ratings to SRTA in the past 3 months
Buy
Buy
1
Hold
0
Sell
0
12-month forecast
Based on 1 Wall Street analyst offering 12-month price targets for SRTA in the last 3 months
Highest
Current 4,53 $
9,50 $ (+109,71%)
Average
9,50 $ (+109,71%)
Lowest
9,50 $ (+109,71%)
Analyst
Recommendation
Action
Price target
Projected
Date
Ben Haynor
Lake Street
Buy
Reiterated
9,50 $
+109,7%
08/05/2026
William Bonello
Craig-Hallum
Buy
Maintained
-
-
06/26/2026
Jon Hickman
Ladenburg Thalmann & Co.
Buy
Reiterated
11,50 $
+153,9%
05/07/2026
Yuan Zhi
B. Riley Securities
Buy
Initiated
8,00 $
+76,6%
03/25/2026
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
2025 թ. սեպ
2025 թ. դեկ
2026 թ. մրտ
2026 թ. հնս
Revenue
49,30 մլն
66,79 մլն
67,38 մլն
72,51 մլն
Cost of goods sold
37,68 մլն
55,12 մլն
53,27 մլն
57,29 մլն
Cost of revenue
37,68 մլն
55,12 մլն
53,27 մլն
57,29 մլն
Research and development expenses
453,00 հզր
-1,35 մլն
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
11,74 մլն
13,99 մլն
14,54 մլն
13,17 մլն
Operating expense
12,19 մլն
15,24 մլն
16,02 մլն
19,80 մլն
Total operating expenses
49,88 մլն
70,35 մլն
69,29 մլն
77,09 մլն
Operating income
-577,00 հզր
-3,57 մլն
-1,90 մլն
-4,58 մլն
Other non operating income
33,00 հզր
1,42 մլն
1,46 մլն
71,00 հզր
EBT including unusual items
-9,66 մլն
-5,39 մլն
2,40 մլն
-10,52 մլն
EBT excluding unusual items
583,00 հզր
-1,51 մլն
27,00 հզր
-4,18 մլն
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
57,42 մլն
-8,83 մլն
2,15 մլն
-10,52 մլն
Net profit margin
116,47%
-13,23%
3,20%
-14,50%
Earnings per share
-
-
0,04
-
Interest and investment income
1,13 մլն
638,00 հզր
473,00 հզր
331,00 հզր
Interest expense
-
-
-
-
Net interest expenses
1,13 մլն
638,00 հզր
473,00 հզր
331,00 հզր
Depreciation and amortization charges
-
-
-
-
EBITDA
-158,00 հզր
-558,00 հզր
1,16 մլն
3,93 մլն
Gain or loss from assets sale
-60,44 մլն
-
344,00 հզր
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
Google Apps